GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $104,628,000 | -17.6% | 2,276,000 | -4.1% | 0.16% | -18.4% |
| Q2 2014 | $126,918,000 | +0.1% | 2,373,200 | 0.0% | 0.19% | -3.6% |
| Q1 2014 | $126,800,000 | -1.7% | 2,373,200 | -1.8% | 0.20% | -4.4% |
| Q4 2013 | $129,055,000 | +6.4% | 2,417,200 | 0.0% | 0.21% | -3.3% |
| Q3 2013 | $121,271,000 | -6.1% | 2,417,200 | -6.5% | 0.21% | -9.4% |
| Q2 2013 | $129,188,000 | – | 2,585,300 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |